These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9563280)

  • 21. Post-kala-azar dermal leishmaniasis associated with AIDS.
    Bittencourt A; Silva N; Straatmann A; Nunes VL; Follador I; Badaró R
    Braz J Infect Dis; 2003 Jun; 7(3):229-33. PubMed ID: 14499047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-kala-azar dermal leishmaniasis associated with AIDS.
    Bittencourt A; Silva N; Straatmann A; Nunes VL; Follador I; Badaró R
    Braz J Infect Dis; 2002 Dec; 6(6):313-6. PubMed ID: 12585976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Indian J Pathol Microbiol; 2003 Apr; 46(2):214-5. PubMed ID: 15022913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.
    Sundar S; Kumar K; Chakravarty J; Agrawal D; Agrawal S; Chhabra A; Singh V
    Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):698-700. PubMed ID: 16325873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-kala-azar dermal leishmaniasis in HIV-coinfected individuals: problems in diagnosis and treatment.
    Ramesh V; Avishek K; Salotra P
    Int J Dermatol; 2015 Jan; 54(1):116-20. PubMed ID: 25209701
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypersensitivity reaction over lesions of post-kala-azar dermal leishmaniasis mimicking type 1 reaction in leprosy.
    Dhar S; Malakar S
    Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):66-7. PubMed ID: 10407631
    [No Abstract]   [Full Text] [Related]  

  • 28. Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis.
    Thakur CP; Narain S; Kumar N; Hassan SM; Jha DK; Kumar A
    Ann Trop Med Parasitol; 1997 Sep; 91(6):611-6. PubMed ID: 9425363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post kala-azar ocular leishmaniasis.
    el Hassan AM; Khalil EA; el Sheikh EA; Zijlstra EE; Osman A; Ibrahim ME
    Trans R Soc Trop Med Hyg; 1998; 92(2):177-9. PubMed ID: 9764325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
    Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
    J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.
    Singh S ; Kumar J; Singh R; Dwivedi SN
    Int J Infect Dis; 2000; 4(4):203-8. PubMed ID: 11231183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post kala-azar dermal leishmaniasis: the Kenyan experience.
    Muigai R; Gachihi GS; Oster CN; Were JB; Nyakundi PM; Chunge CN; Kirigi G; Rashid JR
    East Afr Med J; 1991 Oct; 68(10):801-6. PubMed ID: 1667521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-kala-azar dermal leishmaniasis in the Sudan: peripheral neural involvement.
    Elhassan AM; Ali MS; Zijlstra E; Eltoum IA; Ghalib HW; Ahmed HM
    Int J Dermatol; 1992 Jun; 31(6):400-3. PubMed ID: 1512091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An unusual paediatric case of post-kala-azar dermal leishmaniasis: a hidden parasite under the veil of white.
    Arora A; Mohta A
    Clin Microbiol Infect; 2023 Jun; 29(6):803-804. PubMed ID: 36918142
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: a possible challenge to elimination program in India.
    Das VN; Pandey K; Singh D; Forwood C; Lal CS; Das P
    J Postgrad Med; 2013; 59(3):226-8. PubMed ID: 24029204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-kala-azar dermal leishmanasis occurring after 10 years of treated kala azar.
    Mittal R; Behl PN; Srivastava G
    Int J Dermatol; 2002 Dec; 41(12):875-6. PubMed ID: 12492974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allopurinol therapy in post-kala-azar dermal leishmaniasis.
    Ramesh V
    Acta Derm Venereol; 1996 Jul; 76(4):328-9. PubMed ID: 8869699
    [No Abstract]   [Full Text] [Related]  

  • 39. Atypical disseminated leishmaniasis similar to post-kala-azar dermal leishmaniasis in a Brazilian AIDS patient infected with Leishmania (Leishmania) infantum chagasi: a case report.
    Carnaúba D; Konishi CT; Petri V; Martinez IC; Shimizu L; Pereira-Chioccola VL
    Int J Infect Dis; 2009 Nov; 13(6):e504-7. PubMed ID: 19447660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis.
    Hasnain G; Shomik MS; Ghosh P; Rashid MO; Hossain S; Hamano S; Mondal D
    Am J Trop Med Hyg; 2016 Dec; 95(6):1383-1385. PubMed ID: 27672208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.